制药巨头吉利德周日表示,公司将以每股现金 88 美元价格收购美国生物技术公司 Immunomedics,该收购交易总价为 210 亿美元,这凸显了 Immunomedics 癌症药物业务的价值。
Principled Instructions Are All You Need for Questioning LLaMA-1/2, GPT-3.5/4
Optimizing Sequential Experimental Design with Deep Reinforcement Learning